Top Text Box

New report – Diagnosing COVID-19: A perspective from U.S. patenting activity

A new USPTO report finds that small companies and universities led the way in COVID-19 diagnostic patent filings. Nearly 71% of these filings were from small entities, including 64% of filings from companies and 82% from universities, research institutes and hospitals. Financial support from the U.S. government helped spur this invention—about 10.7% of all COVID-19 diagnostic filings had government support, with the U.S. National Institutes of Health leading other agencies.

For more information, read the report.

A graph that shows bars for micro, small, and undiscounted COVID-19 public patent filings, grouped left to right by company, individual, university/research/hospital, and government.

The USPTO released a report revealing that small companies and universities led the way in developing inventions to
Office of the Chief Economist New working paper: Competitive Dynamism in Nascent Markets - Trademarks and Superstar
The United States Patent and Trademark Office’s (USPTO) Office of the Chief Economist released the 2022 updates to
USPTO's Office of the Chief Economist's latest IP Economic Note examines the impact of the COVID-19 pandemic on

There are currently no upcoming events for this topic.

Subscribe to Office of the Chief Economist news

Sign up for news and alerts from the Office of the Chief Economist. Questions for OCE can be directed to